Free Trial
TSE:CTX

Crescita Therapeutics (CTX) Stock Price, News & Analysis

Crescita Therapeutics logo
C$0.76 0.00 (0.00%)
As of 12:35 PM Eastern

About Crescita Therapeutics Stock (TSE:CTX)

Advanced

Key Stats

Today's Range
C$0.75
C$0.76
50-Day Range
C$0.45
C$0.76
52-Week Range
C$0.40
C$0.76
Volume
20,953 shs
Average Volume
46,005 shs
Market Capitalization
C$14.15 million
P/E Ratio
37.50
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTX Stock News Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Crescita Reports Third Quarter 2025 Results
Crescita Reports Second Quarter 2025 Results
Crescita Therapeutics Inc. (CTX.TO) - Yahoo Finance
Crescita Reports First Quarter 2025 Results
See More Headlines

CTX Stock Analysis - Frequently Asked Questions

Crescita Therapeutics' stock was trading at C$0.48 at the start of the year. Since then, CTX shares have increased by 58.3% and is now trading at C$0.76.

Crescita Therapeutics Inc. (TSE:CTX) released its quarterly earnings results on Tuesday, March, 31st. The company reported ($0.04) EPS for the quarter. The company earned $5.96 million during the quarter. Crescita Therapeutics had a negative trailing twelve-month return on equity of 0.59% and a negative net margin of 0.44%.

Shares of CTX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Crescita Therapeutics investors own include Baytex Energy (BTE), Argonaut Gold (AR), Birchcliff Energy (BIR), Crescent Point Energy (CPG), Enbridge (ENB) and IMV (IMV).

Company Calendar

Last Earnings
3/31/2026
Today
5/05/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:CTX
CIK
N/A
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
37.50
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.61 million
Net Margins
-0.44%
Pretax Margin
N/A
Return on Equity
-0.59%
Return on Assets
-8.26%

Debt

Debt-to-Equity Ratio
2.14
Current Ratio
3.33
Quick Ratio
2.29

Sales & Book Value

Annual Sales
C$21.12 million
Price / Sales
0.67
Cash Flow
C$0.63 per share
Price / Cash Flow
1.20
Book Value
C$0.84 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
18,614,000
Free Float
N/A
Market Cap
C$14.15 million
Optionable
Not Optionable
Beta
-1.34
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (TSE:CTX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners